BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-09-05

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-05	Common Stock	M	10000	$11.05	Acquired	53266	Direct
2013-09-05	Common Stock	S	10000	$70.00	Disposed	43266	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-05	Stock Option (right to buy Common Stock)	$11.05	D	10000	Disposed	2019-03-01	Common Stock (10000)	Direct

F1: Transaction made pursuant to 10b5-1 trading plan executed on May 8, 2013

F2: All shares sold at the same price.

F3: Option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of every month thereafter

F4: Reflects number of stock options outstanding after the transaction from this specific stock option grant.